IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
190.23
+4.32 (2.32%)
At close: Aug 13, 2025, 4:00 PM
190.23
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of $32.34 billion as of August 13, 2025. Its market cap has decreased by -25.98% in one year.
Market Cap
32.34B
Enterprise Value
45.90B
1-Year Change
-25.98%
Ranking
n/a
Category
Stock Price
$190.23
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from $5.46B to $32.34B, an increase of 492.54%. That is a compound annual growth rate of 15.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 31.60B | -11.39% |
| Dec 31, 2024 | 35.67B | -15.54% |
| Dec 29, 2023 | 42.23B | 10.96% |
| Dec 30, 2022 | 38.06B | -29.39% |
| Dec 31, 2021 | 53.90B | 56.91% |
| Dec 31, 2020 | 34.35B | 14.58% |
| Dec 31, 2019 | 29.98B | 27.57% |
| Dec 31, 2018 | 23.50B | 13.60% |
| Dec 29, 2017 | 20.69B | 10.50% |
| Dec 30, 2016 | 18.72B | 121.52% |
| Dec 31, 2015 | 8.45B | 12.33% |
| Dec 31, 2014 | 7.52B | 25.93% |
| Dec 31, 2013 | 5.97B | 9.47% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |